Topical Corticosteroid-Induced Adrenal Insufficiency: A Case Report

Nada Ghazi AlQadri; Nouf Aljomah; Hend M Alotaibi

doi:10.1159/000515734

Topical Corticosteroid-Induced Adrenal Insufficiency: A Case Report

Case Rep Dermatol. 2022 Mar 21;14(1):39-42. doi: 10.1159/000515734. eCollection 2022 Jan-Apr.

Authors

Nada Ghazi AlQadri¹, Nouf Aljomah², Hend M Alotaibi³

Affiliations

¹ College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
² College of Medicine, King Saud University, Riyadh, Saudi Arabia.
³ Department of Dermatology, King Saud University Medical City, Riyadh, Saudi Arabia.

Abstract

Topical Corticosteroids (TCS) are the most commonly prescribed medications in Dermatology practice. They are considered safe and effective if used at the appropriate location and for the appropriate duration. Local side effects due to TCS are not uncommon. However, systemic side effects are rare. Herein, we present a patient who developed adrenal insufficiency secondary to the use of TCS.

Keywords: Adrenal insufficiency; Adrenal suppression; Side effects; Topical corticosteroids.

Publication types

Case Reports